Healthy Monozygotic Twins Born from a Vitrified Blastocyst Derived from a Vitrified Oocyte, and a Highly Efficient Vitrification for Freezing Human Oocytes and Blastsocysts
We used simplified oocyte/embryo vitrification and warming protocols (Irvine Scientific) combined with vitristraws (SciTech Invention) to freeze and thaw human oocytes and blastsocysts. Throughout the year of 2014, twelve recipients were transferred embryos developed from vitrified donor oocytes, and fourteen recipients were transferred embryos developed from fresh donor oocytes at the North Carolina center for reproductive medicine (NCCRM). There were no statistically significant differences in donor age (25.9 ± 3.6 vs 24.9 ± 3.2) and recipient age (43.0 ± 5.4 vs 41.4 ± 6.8), fertilization rates (86.2% vs 87.0%), blastocyst development rates (50.0% vs 53.8%), number of embryo transferred (1.7 ± 0.8 vs 1.9 ± 0.4), clinical pregnancy rates per transfer (75.0% vs 71.4%) and live birth rates per transfer (66.7% vs 57.1%) between vitrified and fresh oocyte cycles, respectively. The results demonstrate that vitrification techniques can be used to cryopreserve human oocytes for future use. We are also reporting the live birth of healthy monozygotic twins resulted from a re-vitrified blastocyst derived from a vitrified oocyte. Oocytes from a 30-year-old donor were vitrified in vitristraws. Seven out of eight oocytes survived after thawing on November 16, 2013. Those seven oocytes were inseminated by intracytoplasmic sperm injection (ICSI) at about 2 hours post thawing. All seven oocytes were tested as fertilized by pronuclear check at 18 hours after ICSI. Those fertilized oocytes showed normal cleavage on day 2 and day 3. Four of them developed to blastsocysts by culturing in continuous single culture medium in a tri-gas incubator for 5 days. Two blastsocysts were transferred to a 43-year-old recipient, but that did not result in a pregnancy. The other two blastsocysts were re-vitrified in a vitristraw. The re-vitrified blastsocysts were thawed and then transferred to the same recipient on May 8, 2014. The patient achieved a normal pregnancy on her second transfer. On June 14, 2014, an ultrasound scan detected two heartbeats in one gestational sac. Two healthy monozygotic boys (weighing 2466g and 2353g) were born on January 13, 2015. To our knowledge, this is the first report of monozygotic twins born from an embryo by twice vitrification at oocyte and blastocyst stage.
Healthy Monozygotic Twins Born from a Vitrified Blastocyst Derived from a Vitrified Oocyte, and a Highly Efficient Vitrification for Freezing Human Oocytes and Blastsocysts, American Journal of BioScience.
Vol. 8, No. 5,
2020, pp. 132-138.
Chen, C. (1986). Pregnancy after human oocytes cryopreservation. Lancet, 327 (8486), 884-886.
Kuleshva L., et al. (1999). Birth following vitrification of a small number of human oocytes. Human and Reproduction, 14 (12), 3077-3079.
Cao, Y., et al. (2009). Comparison of survival and embryonic development in human oocytes cryopreserved by slow-freezing and vitrification. Fertility and Sterility, 92 (4), 1306-1311.
Edgar, D., et al. (2012). A critical appraisal of cryopreservation (slow cooling verus vitrification) of human oocytes and embryos. Human Reproduction Update, 18 (5), 536-554.
Smith, G., et al. (2010). Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertility and Sterility, 94 (6), 2088-2095.
Katayama K., et al. (2003). High survival rate of vitrified human oocytes results in clinical pregnancy. Fertility and Sterility, 80 (1), 223-224.
Kyono, K., et al. (2005). Successful Pregnancy and Delivery After the Transfer of a Single Blastocyst Derived From a Vitrified Mature Human Oocyte. Fertility and Sterility, 84, 1017.e5-e6.
Lucena E., et al. (2013). Successful ongoing pregnancies after vitrification of oocytes. Fertility and Sterility, 86 (1), 108-111.
Garcia-Velasco J., et al. (2013). Five years' experience using oocyte vitirfication to preserve fertility for medical and nonmedical indications. Fertility and Sterility, 99 (7), 1994-1999.
Braga, D., et al. (2016). Freeze-all, oocyte vitrification, or fresh embryo transfer? Lessons from an egg-sharing donation program. Fertility Sterility, 106 (3), 615–622.
Munck, N., et al. (2016). Open versus closed oocyte vitrification in an oocyte donation programme: a prospective randomized sibling oocyte study. Human Reproduction, 31 (2), 377-383.
Crawford, S., et al. (2017). Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013. Fertility and Sterility, 107 (1), 110-118.
Choi D. H., et al. (2000). Pregnancy and delivery of healthy infants developed from blastocyts in an IVF-ET program. Fertility and Sterility, 74 (1), 838-839.
Desai N., et al. (2007). Artificial collapse of mouse and human blastocysts prior to vitrification. Fertility and Sterility, 88 (51), 5343-5344.
Hong S., et al. (2009). Cryopreserved human blastsocysts after vitrification result in excellent implantation and clinical pregnancy rates. Fertility and Sterility, 92 (6), 2062-2064.
Cobo A., et al. (2009). Cumullative outcome after transferring "re-vitrified" embryos in ovum donation cycles conducted with vitrified donors oocytes. Fertility and Sterility, 92 (3), 587.
Anderson, R., et al. (2017). Blastocyst vitrification and preimplantation genetic screening (PGS) has facilitated the routine implementation of “cryo-all” cycles: a change in practice management benefiting both the patients and laboratory. Fertility and Sterility, 108 (3), e352-e353.
Forman, E. J., et al. (2102). Oocyte vitrification does not increase the risk of embryonic aneuploidy or diminish the implantation potential of blastsocysts created after intracytoplasmic sperm injection: a novel, paired randomized controlled trial using DNA fingerprinting. Fertility and Sterility, 98 (3), 644-649.
Cobo, Ana. (2012). Oocyte vitrification: a watershed in ART. Fertility and Sterility, 98 (3), 600-601.
Cobo, a., et al. (2008). Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertility and Sterility, 89 (60), 1657-1664.
Giordana, S. M., et al. (2010). Impact of embryo quality in fresh versus vitrified oocytes in an egg donation program. Fertility and Sterility, 94 (4), s111.
Jones, A. E., et al. (2013). Fresh versus vitrified: results of an egg donor program comparing sibling oocyte outcomes. Fertility and Sterility, 100 (30), s95.
Domingues, T. S., et al. (2014). Egg donation produces similar pregnancy rates with the blastocyst transfer from fresh or vitrified oocytes. Fertility and Sterility, 102 (3), e60.
Homburg, R., et al. (2009). Oocyte vitrification—Women's emancipation set in stone. Fertility and Sterility, 91 (4), 1319-1320.
Cobo, A., et al. (2013). Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients? Fertility and Sterility, 99 (6), 1485-1495.
Gidoni, Y., et al. (2008). Cryopreservation of a mother's oocytes for possible future use by her daughter with Turner syndrome: case report. Fertility and Sterility, 90 (5), e9-e12.
Rybak, e., et al. (2009). Egg freezing, procreative liberty, and ICSI: the double standards confronting elective self-donation of oocytes. Fertility and Sterility, 92 (5), 1509-1512.
Ethics Committee of the American Society for Reproductive Medicine. (2018). Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion. Fertility and Sterility, 110 (6), 1022-1028.
Cobo A., et al. (2010). Use of cryo-banked oocytes in an ovum donation program: a prospective, randomized, controlled, clinic trial. Human Reproduction, 25, 2239-2246.
Cobo A., et al. (2010). Development of a predictive model for donor's vitrified oocyte ‘s survival in an egg-bank. Fertility and Sterility, 94 (4), s20
Shu, y., et al. (2013). Single blastocyst transfer in patients utilizing vitrified donor oocytes from a donor bank. Fertility and Sterility, 100 (3), s166.
Quaas, A., et al. (2012). Egg banking in the USA: current status of commercially available cryopreserved oocytes. Fertility and Sterility, 98 (3), s65.
Fung, M. Y., et al. (2015). The advent of frozen egg banks: a comparison of outcomes to fresh donor eggs. Fertility and Sterility, 104 (3), e32.
Hammond, K. R., et al. (2018). Impact of vitrified egg banking on donor oocyte source: is recruitment by practices a dying ART? Fertility and Sterility, 110 (4), e155-e156.
Asimakopoulos, B., et al. (2011). In vitro maturation and fertilization of vitrified immature human oocytes, subsequent vitrification of produced embryos, and embryo transfer after thawing. ? Fertility and Sterility 95 (6), 2123. e1-e2.
Lamb, J., et al. (2018). Outcomes of vitrified donor oocytes: implantation rates are increased when blastocysts are vitrified prior to embryo transfer. Fertility and Sterility, 109 (3), e33-e34.
Cobo, A., et al. (2013). Outcome of cryotransfer of embryos developed from vitrified oocytes: double vitrification has no impact on delivery rates. Fertility and Sterility, 99 (6), 1623-1630.
Mukaida, T., et al. (2005). Birth After Vitrified Human Oocytes Using Cryoloop Technique. 84 (1), s454
Bonetti, A., et al. (2011). Ultrastructural evaluation of human metaphase II oocytes after vitrification: closed verus open devices. Fertility and Sterility, 95 (3) 928-935.
Taylor, T. H., et al. (2010). Oocyte vitrification: similar results using a straw or cryolock. Fertility and Sterility, 94 (4), s109.
Feng, H. L. and Tsai, T. (2016). Impact of different vitrification devices on oocyte DNA integrity in oocytes. Fertility and Sterility, 106 (3), e140.
Weatherby, F., et al. (2013). Oocyte bank set up by comparing different vitrification devices. Fertility and Sterility, 100 (3), s174.
Mizuno, S., et al. (2014). Comparison of vitrification devices for human embryos between open and closed system. Fertility and Sterility, 102 (3) e122-e123.
Dorfmann, A. D., et al, (2014). Frozen embryo transfers using embryos derived from vitrified donor oocytes from the Fairfax eggbank. 102 (3), e124.
Vaughan, D. A., eat al. (2015). Monozygotic Twinning in IVF: Do They Cluster? Fertility and Sterility, 103 (2) e38-e39.
Liu, H., et al. (2018). Elevated incidence of monozygotic twinning is associated with extended embryo culture, but not with zona pellucida manipulation or freeze-thaw procedure. Fertility and Sterility, 109 (6), 1044-1050.
Tocino, A., et al. (2015). Monozygotic twinning after assisted reproductive technologies: a case report of asymmetric development and incidence during 19 years in an international group of in vitro fertilization clinics. Fertility and Sterility, 103 (5), 1185-1189,
Shipley, S. K., et al. (2003). Factors involved in monozygotic twinning: a three year prospective. Fertility and Sterility, 80 (3), 290-291.
Spandorfer, S. D., et al. (2003). Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. Fertility and Sterility, 80 (3), 75-76.
Vitthala S, et al. (2009). The risk of monozygotic twins after assisted reproductive technology: a systematic review and meta-analysis. Human and Reproduction Update, 15 (1), 45-55.
Knopman JM, et al. (2014). What makes them split? Identifying risk factors that lead to monozygotic twins after in vitro fertilization. Fertility and Sterility, 102 (1), 82-89.
Shipley, S. K., et al. (2008). Analysis of biochemical and biophysical risk factors for monozygotic twinning observed within an in vitro fertilization program. Fertility and Sterility, 90, Supplement, s215-s216.
Mateiael, I., et al. (2016). Do ARTs affect the incidence of monozygotic twinning? Human and Reproduction, 15 (11), 2435-2441.
Papanikolaou, E. G., et al. (2010). Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. Fertility and Sterility, 93 (2), 592-597.
Mukaida, T., et al. (2007) Does vitrified blastocyst (BL) transfer increase the incidence of monozygotic twinning (MZT)? (analysis of 1,113 cycles for 3 years). Fertility and Sterility, 88 (1), s434.